In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis.

por Girard, A E, Girard, D, Gootz, T D, Faiella, J A, Cimochowski, C R
Publicado 1995

Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution.

por Girard, A E, Girard, D, English, A R, Gootz, T D, Cimochowski, C R, Faiella, J A, Haskell, S L, Retsema, J A
Publicado 1987